We are live on
!
Find out more
NI
Nextech Invest Portfolio holdings
AUM
$1.42B
1-Year Est. Return
304.47%
This Fund
S&P 500
This Quarter
Est. Return
-22.08%
1 Year Est. Return
+304.47%
3 Year Est. Return
+631.11%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$380M
AUM Growth
–
Cap. Flow
+$464M
Cap. Flow
% of AUM
122.34%
Top 10 Holdings %
Top 10 Hldgs %
97.96%
Holding
11
New
11
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
EQRX
EQRx, Inc. Common Stock
EQRX
|
+$124M |
| 2 |
Revolution Medicines
RVMD
|
+$83.7M |
| 3 |
KNTE
Kinnate Biopharma Inc. Common Stock
KNTE
|
+$63.4M |
| 4 |
Tyra Biosciences
TYRA
|
+$50M |
| 5 |
PMV Pharmaceuticals
PMVP
|
+$33.5M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 100% |
Similar funds
BC
IHG
PTC
PPC
KCMH
APCM
CBA
KC
Nextech Invest's Q4 2021 Portfolio in Review
Q4 2021 is the first quarter with a 13F filing on record for Nextech Invest, which disclosed 11 positions worth $380M. Its ten largest holdings account for 98% of the portfolio.
Its largest position is EQRx, Inc. Common Stock: 13,104,424 shares worth $89.4M.
By sector, the portfolio is most concentrated in Healthcare at 100% of assets.
- Nextech Invest's largest Q4 2021 buy was EQRx, Inc. Common Stock: 13,104,424 shares worth $89.4M.
- Nextech Invest's ten largest holdings make up 98% of its $380M portfolio in Q4 2021.
- Nextech Invest disclosed 11 positions in Q4 2021, its first 13F filing on record.
Based on Nextech Invest's 13F filing for Q4 2021, filed 14 Feb 2022.